Cynata Therapeutics Limited (AU:CYP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cynata Therapeutics Limited has fully complied with the ASX Corporate Governance Council’s recommendations throughout the financial year ended 30 June 2024, as detailed in their corporate governance statement. This statement, which outlines the roles and responsibilities of the board and management, is available on the company’s website. The company has been transparent with its governance practices, ensuring accountability and thorough oversight.
For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.